{
  "127427":{
    
  },
  "1274442":{
    "Figure_1.tif":{
      "4":{
        "descriptions":[
          "(4) and vurtoxin "
        ],
        "rois":[
          {
            "x":9,
            "y":9,
            "x2":989,
            "y2":1071
          }
        ]
      },
      "11":{
        "descriptions":[
          "(11) are indicated by horizontal bars."
        ],
        "rois":[
          {
            "x":9,
            "y":9,
            "x2":989,
            "y2":1071
          }
        ]
      }
    }
  },
  "1276608":{
    "Figure_2.tif":{
      "A":{
        "descriptions":[
          "A: After starvation overnight, bladder cancer T24 cells were treated with SFN at the concentrations indicated for 24 h, cell migration was measured by a cell migration assay using the ThinCert cell culture inserts (Greiner Bio-One Ltd.). Each bar represents the mean ?? SD of 3 replicates"
        ],
        "rois":[
          {
            "x":8,
            "y":6,
            "x2":1001,
            "y2":780
          }
        ]
      },
      "B":{
        "descriptions":[
          ". B: Effect of pre-treatment of 3-MA on cell migration. DMSO (0.1% was used as a control). Statistical significance from the control, *p"
        ],
        "rois":[
          {
            "x":1150,
            "y":6,
            "x2":2212,
            "y2":746
          }
        ]
      }
    }
  },
  "1278134":{
    "Figure_2.tif":{
      "a":{
        "descriptions":[
          "a) Fluorescent microarray scanner measuring relative abundance of initiator prior to polymerization labeling. Scale bar???=???1 mm"
        ],
        "rois":[
          {
            "x":5,
            "y":1323,
            "x2":1078,
            "y2":2112
          }
        ]
      },
      "b":{
        "descriptions":[
          ". b) Relative initiator concentration on surface for spots printed from the indicated concentration of biotinylated-BSA and reacted with the SA-initiator complex. Measurements based on initiator fluorescence (ex/em???=???525/545 nm)"
        ],
        "rois":[
          {
            "x":6,
            "y":583,
            "x2":1084,
            "y2":1291
          }
        ]
      },
      "c":{
        "descriptions":[
          ". c) Thickness of spots of indicated Bio-BSA concentration. Data are mean ?? standard deviation. n???=???16."
        ],
        "rois":[
          {
            "x":5,
            "y":1323,
            "x2":1078,
            "y2":2112
          }
        ]
      },
      "C":{
        "descriptions":[
          
        ],
        "rois":[
          {
            "x":5,
            "y":5,
            "x2":824,
            "y2":598
          }
        ]
      }
    }
  },
  "1278139":{
    "Figure_3.tif":{
      "a":{
        "descriptions":[
          "a) Greyscale image from optical document scanner after Polymer Dye Labeling with Evans Blue dye"
        ],
        "rois":[
          {
            "x":3,
            "y":3,
            "x2":773,
            "y2":1203
          }
        ]
      },
      "b":{
        "descriptions":[
          ". b) Greyscale image from optical document scanner after Polymer Dye Labeling with eosin dye. Scale bars???=???1 mm"
        ],
        "rois":[
          {
            "x":675,
            "y":3,
            "x2":1353,
            "y2":704
          }
        ]
      },
      "c":{
        "descriptions":[
          ". c) darkness of Evans Blue dyed spots of indicated Bio-BSA concentration"
        ],
        "rois":[
          {
            "x":3,
            "y":3,
            "x2":773,
            "y2":1203
          }
        ]
      },
      "D":{
        "descriptions":[
          
        ],
        "rois":[
          {
            "x":718,
            "y":722,
            "x2":1346,
            "y2":1208
          }
        ]
      },
      "d":{
        "descriptions":[
          ". d) Darkness of eosin dyed spots of indicated Bio-BSA concentration. Data in c) and d) are mean ?? standard deviation. n???=???12."
        ],
        "rois":[
          {
            "x":3,
            "y":3,
            "x2":773,
            "y2":1203
          }
        ]
      }
    }
  },
  "127999":{
    
  },
  "128175":{
    
  },
  "1282838":{
    
  },
  "1282976":{
    
  },
  "1286277":{
    "Figure_4.tif":{
      "A":{
        "descriptions":[
          "(A) BLI curves generated with a panel of CD4bs-directed antibodies immobilized on anti-human IgG Fc sensors and a serial dilution (200 nM???6.25 nM) of negatively selected SOSIP trimers in solution as the analyte. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":3861,
            "y2":5017
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Similar BLI curves obtained with glycan-directed bNAbs."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":3861,
            "y2":5017
          }
        ]
      }
    }
  },
  "1288654":{
    "Figure_4.tif":{
      "A":{
        "descriptions":[
          "(A) Inhibiting GSK3 activity by expression of dominant-negative GSK3 (dnGSK3), or treating explants with a GSK3 inhibitor BIO one hour prior to observation, led to extensive aggregation of PAPC in the cytoplasm in animal cap cells (arrowheads). A putative phosphorylation-mimic mutant PAPC-SD, which carries S816 and S820 to aspartic acid mutations, was resistant to dnGSK3 expression and remained on the plasma membrane. "
        ],
        "rois":[
          
        ]
      },
      "B":{
        "descriptions":[
          "(B) PAPC was not efficiently degraded in DMZ explants expressed with dominant-negative GSK3 (dnGSK3) at stage 15 and formed cytoplasmic aggregates. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":980,
            "y2":397
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) GST-tagged PAPC was expressed in the dorsal marginal zone. When embryos reached the gastrula stage, PAPC-GST was partially purified with Glutathione Sepharose 4B. Phosphorylated PAPC (pPAPC) was detected by anti-phosopho-PAPC antibody, raised against phosphorylated DSR peptide as an antigen. The pPAPC signal was abolished by treating the extract with lambda protein phosphatase (PPase). The recombinant C-terminal domain of PAPC was phosphorylated in vitro in the presence of recombinant GSK3, as confirmed by a Western blot using anti-pPAPC antibody. Total input of PAPC was estimated by anti-GST antibody."
        ],
        "rois":[
          {
            "x":12,
            "y":519,
            "x2":920,
            "y2":742
          }
        ]
      }
    }
  },
  "1290007":{
    "Figure_6.tif":{
      "A":{
        "descriptions":[
          "(A) Infection profile 42 dpi for FVB/N mice infected orally with107 CFUs of wt Y. pseudotuberculosis (n = 20) and indicated mutant strains (each group n = 16). The infections were monitored by IVIS at certain intervals up to 42 dpi. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":960,
            "y2":527
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Heatmap showing differences in clearance (by p-value) between wt and indicated mutant strains at different time points during the 42 day infection period. Heatmap color scale, from green to yellow, was adjusted according to p-values from 1 to 0. p-values were calculated with 2??2 contingency table by Fisher???s Exact Test, see also S6 Table. "
        ],
        "rois":[
          {
            "x":2,
            "y":541,
            "x2":938,
            "y2":1033
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Motility profile of wt Y. pseudotuberculosis and indicated mutant strains under anaerobic conditions at 26??C. Images were captured by the ChemiDoc XRS System (Bio-Rad), showing the bioluminescent signal produced by Y. pseudotuberculosis YPIII/pIBX."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "1294491":{
    
  },
  "1296623":{
    
  },
  "1296632":{
    
  },
  "1300495":{
    
  },
  "1302824":{
    "Figure_5.tif":{
      "E":{
        "descriptions":[
          ". E. DNA sequences of 39 cloned Pax3-Foxo1 PCR fragments from CRISPR-Cas9 treated fore limb (6 different) and of 34 cloned Pax3-Foxo1 PCR fragments from CRISPR-Cas9 treated hind limb (3 different) myoblasts"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2453,
            "y2":2640
          }
        ]
      },
      "F":{
        "descriptions":[
          ". F. Co-localization frequencies of Pax3 and Foxo1 in Foxo1-inv+/+ fore limb, hind limb, and MEFs used in B"
        ],
        "rois":[
          {
            "x":836,
            "y":2312,
            "x2":2453,
            "y2":2640
          },
          {
            "x":0,
            "y":2641,
            "x2":2453,
            "y2":3246
          }
        ]
      },
      "A":{
        "descriptions":[
          "A. Schematic representation of the position of the Pax3 forward (P-F) and reverse (P-R) PCR primers upstream and downstream of the Pax3 breakpoint in intron 7 (DSB) and of the Foxo1 forward (F-F) and reverse (F-R) PCR primers upstream and downstream of the Foxo1 breakpoint in intron 1 (DSB). The P-F and F-R primer pair amplify the Pax3-Foxo1 fusion"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2453,
            "y2":2640
          }
        ]
      },
      "G":{
        "descriptions":[
          ". G. Agarose gel and DNA sequence of a partial Pax3-Foxo1 fusion cDNA fragment showing the correctly spliced Pax3 exon7-Foxo1 exon2 fusion after RT-PCR of RNA from CRISPR-Cas9 treated Foxo1-inv+/+ fore limb myoblasts."
        ],
        "rois":[
          {
            "x":0,
            "y":2641,
            "x2":2453,
            "y2":3246
          }
        ]
      },
      "B":{
        "descriptions":[
          ". B. Agarose gel showing the PCR products obtained using the P-F/F-R primer pair and DNA from Foxo1-inv+/+ hind limb DNA without (lane 1) and with (lane 2) CRISPR-Cas9 treatment, form Foxo1-inv+/+ fore limb DNA without (lane 3) and with (lane 4) CRISPR-Cas9 treatment, from wild type fore limb DNA with CRISPR-Cas9 treatment (lane 5), and from Foxo1-inv+/+ MEF DNA with CRISPR-Cas9 treatment (lane 6). M is 100 bp ladder molecular weight marker. The position of the expected size of the cleanly ligated Pax3-Foxo1 fusion fragment is indicated on the right (251 bp)"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2453,
            "y2":2640
          }
        ]
      },
      "C":{
        "descriptions":[
          ". C. Agarose gel showing the Pax3 PCR fragments containing the RH30-like Pax3 breakpoint from Foxo1-inv+/+ fore limb myoblast DNA not treated with CRISPR-Cas9 without (lane1) and with (lane 2) MaeIII digest, treated with CRISPR-Cas9 without (lane 3) and with (lane 4) MaeIII digest and Foxo1-inv+/+ MEF DNA treated with CRISPR-Cas9 without (lane 5) and with (lane 6) MaeIII digest. Expected fragment sizes are indicated on the right. Fully modified CRISPR-Cas9/NHEJ DSBs do not cut with MaeIII. Beneath the gel is a table with the relative fragment intensities as measured with a BIO-RAD ChemiDoc imaging system. Underneath the table is a histogram giving a graphic representation of the relative band intensities"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2453,
            "y2":2640
          }
        ]
      },
      "D":{
        "descriptions":[
          ". D. Same analysis as in C but for the Foxo1 fragment containing the RH30-like breakpoint digested with DdeI. The table underneath shows the relative fragment intensities as measured with a BIO-RAD ChemiDoc imaging system. Underneath the table is histogram giving a graphic representation of the relative band intensities"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2453,
            "y2":2640
          }
        ]
      }
    }
  },
  "1305081":{
    
  },
  "1310915":{
    "Fig_4.tif":{
      "A":{
        "descriptions":[
          "(A) or centrifuged for detecting micronemal proteins secreted in the medium and present in sporozoites (pellet) by western blotting ",
          "(A) Effect of SB203580 on micronemal protein distribution onto the surface E. tenella. This was determined by immunofluorescence. Sporozoites in PBS at 4??C were used as a negative control. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2021,
            "y2":890
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B). ",
          "(B) Effect of SB203580 on micronemal protein secretion. This was evaluated by western blotting in the supernatants and parasite lysates. Profilin was used as a control of the number of sporozoites. Quantification of secreted micronemal proteins in supernatants was performed using Bio-Profil Bio-1D++ software and is represented by histograms compared to the micronemal protein content in sporozoites. Data are representative of 2 experiments."
        ],
        "rois":[
          {
            "x":0,
            "y":891,
            "x2":2021,
            "y2":4799
          }
        ]
      }
    }
  },
  "1315533":{
    
  },
  "1316703":{
    "Fig_10.tif":{
      "12":{
        "descriptions":[
          "(12), hexamers "
        ],
        "rois":[
          {
            "x":5,
            "y":4,
            "x2":959,
            "y2":1839
          }
        ]
      },
      "5":{
        "descriptions":[
          ", 5-, or 10-fold molar excess of the 22-peptide NWVSAAKFESTDGSTDYGIYQV (2.5 ??, 5 ??, or 10 ??, respectively) or without ligand "
        ],
        "rois":[
          
        ]
      },
      "6":{
        "descriptions":[
          "(6), and trimers "
        ],
        "rois":[
          {
            "x":5,
            "y":4,
            "x2":959,
            "y2":1839
          }
        ]
      },
      "0":{
        "descriptions":[
          "(0), subjected to cross-linking with bis[sulfosuccinimidyl] suberate (BS3), and then analyzed using size exclusion chromatography as described in ???Materials and Methods???. The void volume (V0) and elution volumes of molecular weight standards (Bio-Rad) used for column calibration are shown as vertical dotted lines. The positions of HtrA dodecamers "
        ],
        "rois":[
          
        ]
      },
      "3":{
        "descriptions":[
          "(3) are indicated with arrows. A representative elution profile is shown; a.u., arbitrary units."
        ],
        "rois":[
          {
            "x":5,
            "y":4,
            "x2":959,
            "y2":1839
          }
        ]
      }
    }
  },
  "1318337":{
    "Fig_2.tif":{
      "A":{
        "descriptions":[
          "(A) LiCl, "
        ],
        "rois":[
          {
            "x":4,
            "y":4,
            "x2":1596,
            "y2":644
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) BIO, and "
        ],
        "rois":[
          {
            "x":25,
            "y":644,
            "x2":1546,
            "y2":1333
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Wnt antagonist sFRP4 (* piiiiiiivviv"
        ],
        "rois":[
          {
            "x":23,
            "y":1380,
            "x2":1552,
            "y2":2082
          }
        ]
      }
    }
  },
  "1318340":{
    "Fig_3.tif":{
      "vi":{
        "descriptions":[
          "(vi) 1ng/mL sFRP4 in both (A) and (B). Scale bar = 10??M."
        ],
        "rois":[
          
        ]
      },
      "i":{
        "descriptions":[
          "(i) non-induced control media, "
        ],
        "rois":[
          {
            "x":1058,
            "y":2,
            "x2":2048,
            "y2":855
          }
        ]
      },
      "v":{
        "descriptions":[
          "(v) 100pg/mL sFRP4, and "
        ],
        "rois":[
          {
            "x":2,
            "y":8,
            "x2":998,
            "y2":855
          }
        ]
      },
      "iv":{
        "descriptions":[
          "(iv) 0.5??M BIO, "
        ],
        "rois":[
          
        ]
      },
      "ii":{
        "descriptions":[
          "(ii) adipogenic control, (iii) 10mM LiCl, "
        ],
        "rois":[
          
        ]
      }
    }
  },
  "1318342":{
    "Fig_4.tif":{
      "II":{
        "descriptions":[
          
        ],
        "rois":[
          {
            "x":5,
            "y":4,
            "x2":1468,
            "y2":1083
          }
        ]
      },
      "vi":{
        "descriptions":[
          "(vi) 1ng/mL sFRP4. Scale bar = 250??M (B) Quantification of the stained lipid droplets were performed using the eluted Oil red O stain via measuring absorbance at 510nm. The readings were normalised to background values of non-induced control ADSCs. The values of all treatment conditions were compared to the adipogenic control group (* p"
        ],
        "rois":[
          
        ]
      },
      "IV":{
        "descriptions":[
          
        ],
        "rois":[
          {
            "x":47,
            "y":1098,
            "x2":1496,
            "y2":1911
          },
          {
            "x":5,
            "y":4,
            "x2":1468,
            "y2":1083
          }
        ]
      },
      "i":{
        "descriptions":[
          "(i) non-induced control, "
        ],
        "rois":[
          
        ]
      },
      "v":{
        "descriptions":[
          "(v) 100pg/mL sFRP4, and "
        ],
        "rois":[
          
        ]
      },
      "V":{
        "descriptions":[
          
        ],
        "rois":[
          {
            "x":47,
            "y":1098,
            "x2":1496,
            "y2":1911
          }
        ]
      },
      "iv":{
        "descriptions":[
          "(iv) 0.5??M BIO, "
        ],
        "rois":[
          
        ]
      },
      "ii":{
        "descriptions":[
          "(ii) adipogenic control, (iii) 10mM LiCl, "
        ],
        "rois":[
          
        ]
      }
    }
  },
  "1318344":{
    "Fig_5.tif":{
      "A":{
        "descriptions":[
          "(A) PPAR??, "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1229,
            "y2":300
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) C/EBP??, and "
        ],
        "rois":[
          {
            "x":1230,
            "y":0,
            "x2":2049,
            "y2":300
          },
          {
            "x":0,
            "y":301,
            "x2":2049,
            "y2":1616
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Acetyl CoA carboxylase adipogenic marker proteins. All values were compared to the adipogenic media control (*p"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1229,
            "y2":300
          }
        ]
      }
    }
  },
  "1318347":{
    "Fig_6.tif":{
      "A":{
        "descriptions":[
          "(A) Before and ",
          "(A) and ",
          "(A) and 250??M in "
        ],
        "rois":[
          {
            "x":3,
            "y":2,
            "x2":2048,
            "y2":472
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) after Oil red O staining. Treatment conditions were (i) non-induced control media, (ii) adipogenic control, (iii) 0.5??M BIO, (iv) 1ng/mL sFRP4, and (v) 0.5??M BIO + 1ng/mL sFRP4 in both ",
          "(B). Scale bar = 10??M in ",
          "(B). "
        ],
        "rois":[
          {
            "x":4,
            "y":486,
            "x2":2032,
            "y2":967
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Quantification of the stained lipid droplets were performed using the eluted Oil red O stain via measuring absorbance at 510nm. The readings were normalised to background values of non-induced control ADSCs. The values of all treatment conditions were compared to the adipogenic control group (** p"
        ],
        "rois":[
          {
            "x":576,
            "y":999,
            "x2":1697,
            "y2":1543
          },
          {
            "x":4,
            "y":486,
            "x2":2032,
            "y2":967
          }
        ]
      }
    }
  },
  "1318349":{
    
  },
  "1319834":{
    "Fig_4.tif":{
      "E":{
        "descriptions":[
          "(E) Capacity of fiber containing fractions in inhibition of Ad5-GFP infection in A549 cells. The fractions containing fiber molecule (B10, B12, C5 and D7) were first concentrated by a factor of 5 and subsequently diluted as indicated with fresh cell culture media, 200 ??l of each dilution were applied to each well of A549 cells cultured in 24-well plates for 30 min at 37??C. Following two washes with fresh media, cells were infected with Ad5-GFP virus at a MOI of 100 for 1 hr at 37??C. The percentage of infected cells was analyzed with FACS assay as GFP positive cells at 24 hpi"
        ],
        "rois":[
          {
            "x":54,
            "y":1847,
            "x2":933,
            "y2":2250
          },
          {
            "x":892,
            "y":25,
            "x2":1459,
            "y2":491
          }
        ]
      },
      "F":{
        "descriptions":[
          "(F) and penton base "
        ],
        "rois":[
          {
            "x":892,
            "y":25,
            "x2":1459,
            "y2":491
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) Elution profile of gel filtration chromatography. One ml of concentrated Ad5 CM was separated by Superdex 200 column at a flow rate of 0.5 ml/min. Protein concentration of each fraction was monitored with absorbance at 280 nm (Y axis). The indicated fractions (arrow), named according to their positions on the collection rack, were selected for the analyses performed in panels B to E. ",
          "(A); lower panel: SimplyBlue staining in the corresponding SDS-PAGE gel. Fiber molecules were abundant in B12 and C5 fractions, penton base mainly in B12 fraction. "
        ],
        "rois":[
          {
            "x":523,
            "y":1263,
            "x2":1456,
            "y2":1439
          },
          {
            "x":835,
            "y":1441,
            "x2":1144,
            "y2":1590
          },
          {
            "x":1189,
            "y":872,
            "x2":1446,
            "y2":1124
          }
        ]
      },
      "PC":{
        "descriptions":[
          "; PC: positive control samples (infection without pre-treatment with Ad5 CM)."
        ],
        "rois":[
          
        ]
      },
      "PB":{
        "descriptions":[
          "(PB) in the fractions from "
        ],
        "rois":[
          {
            "x":892,
            "y":25,
            "x2":1459,
            "y2":491
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Upper panel: western-blot analysis for the detection of fiber "
        ],
        "rois":[
          {
            "x":1147,
            "y":1441,
            "x2":1456,
            "y2":1590
          },
          {
            "x":523,
            "y":1440,
            "x2":832,
            "y2":1590
          },
          {
            "x":37,
            "y":867,
            "x2":1182,
            "y2":1201
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Identification of Ad structure proteins in fiber-containing fractions by cell surface binding assay. A549 cells were incubated with 200 ??l of the indicated fractions for 15 min on ice. Cells were then washed and incubated with the 4D2 anti-fiber mAb in combination with rabbit anti-penton base antibody, followed by staining with Alexa Flour 647 conjugated goat anti-mouse IgG and Alexa Flour 488 conjugated goat anti-rabbit antibody. Parallel samples stained with 4D2 mAb in combination with FITC-conjugated goat anti-hexon antibody were then stained with Alexa Flour 647 conjugated goat anti-mouse IgG. The cells were analyzed in FACS Calibur for the double stained cells. The dot-plots shown are representative of three independent experiments. Fiber, penton base and hexon were detected in B12 fraction, whereas only hexon and fiber were detected in C5 fraction. ",
          "(C). The membrane was scanned by a PharosFX Plus system (Bio-Rad) using 3-laser channels for the visualization of specific binding bands for different antigens. SimplyBlue protein staining of the native PAGE gel (left panel) depicts that B12 and C5 fraction contain protein complexes of about 720 kDa and 440 kDa, respectively. The area on the gel corresponding to the western-blot data shown in the right panel is indicated by the rectangle. Fiber, hexon and penton base were detected in the B12 fraction, whereas fiber and hexon were detected in the C5 fraction. "
        ],
        "rois":[
          {
            "x":523,
            "y":1592,
            "x2":1457,
            "y2":1745
          },
          {
            "x":4,
            "y":1231,
            "x2":510,
            "y2":1832
          },
          {
            "x":2,
            "y":510,
            "x2":1450,
            "y2":856
          }
        ]
      },
      "NC":{
        "descriptions":[
          ". NC: negative control samples (mock infection)"
        ],
        "rois":[
          {
            "x":892,
            "y":25,
            "x2":1459,
            "y2":491
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D) Characterization of structural protein complexes by native PAGE and western-blot analysis. Proteins in different fractions were separated by pre-casted 4???20% native PAGE gel and blotted onto PVDF membrane. The membrane was probed with anti-fiber, anti-penton base and anti-hexon antibodies simultaneously and then further probed with the secondary antibodies used in "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":837,
            "y2":438
          }
        ]
      }
    }
  },
  "1320080":{
    
  },
  "1326103":{
    "Fig_3.tif":{
      "E":{
        "descriptions":[
          "(E) Detection of 6-FAM labeled siRNA distribution by fluorescence microscopy in liver 4 h after intravenous injection. The microvasculature was visualized with red signals by intravenous injection of Texas Red conjugated dextran. Left, 6-FAM labeled siRNA; right, merged images of the left panel and Texas Red stained blood vessels with DAPI. Scale bar, 50 ??m. "
        ],
        "rois":[
          {
            "x":1005,
            "y":3289,
            "x2":1602,
            "y2":3826
          },
          {
            "x":1839,
            "y":2952,
            "x2":3554,
            "y2":3926
          },
          {
            "x":3429,
            "y":2533,
            "x2":3725,
            "y2":2792
          }
        ]
      },
      "F":{
        "descriptions":[
          "(F) Quantitative analysis of fluorescence intensity at 4 and 12 h. Fluorescence of 6-FAM was calculated as fluorescence intensity/area and normalized against that of control sections. Data represent mean ?? SEM. Liver: n = 12???15 fields of view (FOV) from 4 mice; Spleen: n = 12???20 FOV from 4 mice; Kidney: n = 8???16 FOV from 4 mice; HCT116: n = 21???24 FOV of 6 tumors; HT29: n = 8???24 FOV of 6 tumors (Wilcoxon rank test)."
        ],
        "rois":[
          {
            "x":1005,
            "y":3846,
            "x2":1602,
            "y2":4295
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) CT imaging of Alexa Fluor 750 labeled siRNA in FaDu tumors at 4 and 12 h. The red dashed circles indicate tumors. "
        ],
        "rois":[
          {
            "x":2088,
            "y":4056,
            "x2":3547,
            "y2":4922
          },
          {
            "x":93,
            "y":0,
            "x2":1514,
            "y2":499
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Ex vivo imaging at 9 and 16 h comparing sCA with IF and Atelo. "
        ],
        "rois":[
          {
            "x":2088,
            "y":4056,
            "x2":3547,
            "y2":4922
          },
          {
            "x":1838,
            "y":0,
            "x2":3641,
            "y2":1388
          },
          {
            "x":984,
            "y":931,
            "x2":1513,
            "y2":1245
          },
          {
            "x":984,
            "y":558,
            "x2":1513,
            "y2":871
          }
        ]
      },
      "IF":{
        "descriptions":[
          "(IF), AteloGene (Atelo), or sCA by intravenous administration via tail vein. Left panel: whole mouse imaging; right panel: CT scan images of lung and liver. "
        ],
        "rois":[
          
        ]
      },
      "C":{
        "descriptions":[
          "(C) Detection of siRNA in HCT116 tumor at 4 h by light sheet fluorescence microscopy. The microvasculature was visualized as red signals by intravenous injection of Texas Red conjugated dextran. Green: 6-FAM labeled siRNA. Scale bar, 10 ??m. "
        ],
        "rois":[
          {
            "x":60,
            "y":3846,
            "x2":928,
            "y2":4763
          },
          {
            "x":2088,
            "y":4056,
            "x2":3547,
            "y2":4922
          },
          {
            "x":3429,
            "y":1518,
            "x2":3726,
            "y2":1846
          },
          {
            "x":1846,
            "y":1498,
            "x2":3752,
            "y2":2884
          },
          {
            "x":2677,
            "y":1439,
            "x2":2976,
            "y2":2881
          },
          {
            "x":1838,
            "y":0,
            "x2":3641,
            "y2":1388
          },
          {
            "x":984,
            "y":931,
            "x2":1513,
            "y2":1245
          },
          {
            "x":0,
            "y":1502,
            "x2":1594,
            "y2":2497
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D) IVIS spectrum CT imaging 12 h after treatment. Mice were treated with 40 ??g of Alexa Fluor 750 labeled siRNA delivered with Invivofectamine 2.0 "
        ],
        "rois":[
          {
            "x":90,
            "y":3114,
            "x2":1050,
            "y2":3826
          },
          {
            "x":1005,
            "y":4314,
            "x2":1602,
            "y2":4763
          },
          {
            "x":3429,
            "y":2533,
            "x2":3725,
            "y2":2792
          },
          {
            "x":3429,
            "y":1518,
            "x2":3726,
            "y2":1846
          },
          {
            "x":3032,
            "y":1518,
            "x2":3330,
            "y2":2791
          },
          {
            "x":1846,
            "y":1498,
            "x2":3752,
            "y2":2884
          },
          {
            "x":142,
            "y":557,
            "x2":931,
            "y2":1244
          }
        ]
      }
    }
  },
  "1329173":{
    
  },
  "1329176":{
    
  },
  "1330593":{
    "Fig_5.tif":{
      "A":{
        "descriptions":[
          ". A. Cellular compromise, cellular function and maintenance (score = 45). Red, upregulated proteins; green, significantly downregulated proteins; white, proteins known to be in the network but not identified in this study. The color depth indicates the magnitude of the change in protein expression levels. The shape is indicative of the molecular class (i.e protein family). Lines connecting the molecules indicate molecular relationships. Dashed lines indicate indirect interactions, and solid lines indicate direct interactions. The arrow styles indicate specific molecular relationships and the directionality of the interaction"
        ],
        "rois":[
          {
            "x":24,
            "y":23,
            "x2":3163,
            "y2":4760
          }
        ]
      },
      "B":{
        "descriptions":[
          ". B. Network build up from the three most significant bio-functions (activation Z score >2 or "
        ],
        "rois":[
          
        ]
      }
    }
  },
  "1332811":{
    "Fig_5.tif":{
      "A":{
        "descriptions":[
          "(A) Experimental scheme for Rad52 knockdown experiments. Rad52 knockdown was achieved by an initial siRNA treatment followed by a subsequent siRNA treatment in conjunction with transfection of an I-SceI expression plasmid. Following treatment and I-SceI-induced DSB formation, cells were either harvested for Western blot detection of Rad52 or selected with media containing puromycin for 10 days to assay Alu-mediated deletions. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1224,
            "y2":1487
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Western blot showing Rad52 siRNA knockdown compared to control siRNA treatment. M???Precision Plus Protein WesternC Standards (Bio-Rad). "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1224,
            "y2":1487
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) The average number of puror colonies is plotted for the indicated AARP HEK293FRT cells treated with control or Rad52 siRNA. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1224,
            "y2":1487
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D) The percentage of Alu/Alu recombination or NHEJ as determined by PCR and sequence analysis of DNA repair products from isolated puror colonies that were treated with control (Ctrl) or Rad52 siRNA is shown."
        ],
        "rois":[
          {
            "x":0,
            "y":1488,
            "x2":1224,
            "y2":2258
          }
        ]
      }
    }
  },
  "1336665":{
    "Fig_4.tif":{
      "A":{
        "descriptions":[
          "(A) Probes with a fold change ??? 1.8 between CTRL and MT1 cells in at least 1 point in the time course were selected and displayed as a heat map based on unsupervised hierarchical clustering. Red colour indicates genes that were up-regulated and green colour indicates genes that were down-regulated. Black indicates genes whose expression is unchanged in MT1 cells as compared to CTRL cells. "
        ],
        "rois":[
          {
            "x":0,
            "y":1,
            "x2":828,
            "y2":1659
          },
          {
            "x":898,
            "y":0,
            "x2":1894,
            "y2":2208
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Venn diagram showing the overlap of modulated genes at the three time points. Numbers in italics, red, and underlined represent up-, contra-, and down-regulated genes, respectively. Numbers in brackets refer to the numbers of genes modulated at each time point. Venn analyses were performed using gene symbols. "
        ],
        "rois":[
          {
            "x":4,
            "y":1677,
            "x2":858,
            "y2":2358
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Bio-function analysis of the dataset of genes differentially regulated upon MT1-MMP expression was performed in IPA. The significance is expressed as a negative log of p-value, which was calculated using the right-tailed Fisher's Exact Test. The orange line represents the threshold p value of 0.05."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "1336667":{
    "Fig_5.tif":{
      "A":{
        "descriptions":[
          "(A) Probes with a fold change ??? 1.8 between CTRL and MT1 cells in at least 1 point in the time course were selected and displayed as a heat map based on unsupervised hierarchical clustering. Red colour indicates genes that were up-regulated and green colour indicates genes that were down-regulated. Black indicates genes whose expression is unchanged in MT1 cells as compared to CTRL cells. "
        ],
        "rois":[
          {
            "x":0,
            "y":1,
            "x2":809,
            "y2":1815
          },
          {
            "x":882,
            "y":1,
            "x2":1878,
            "y2":2117
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Venn diagram showing the overlap of modulated genes at the three time points. Numbers in italics, red, and underlined represent up-, contra-, and down-regulated genes, respectively. Numbers in brackets refer to the numbers of genes modulated at each time point. Venn analyses were performed using gene symbols. "
        ],
        "rois":[
          {
            "x":4,
            "y":1823,
            "x2":920,
            "y2":2466
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Bio-function analysis of the dataset of genes differentially regulated upon MT1-MMP expression was performed in IPA. The significance is expressed as a negative log of p-value, which was calculated using the right-tailed Fisher's Exact Test. The orange line represents the threshold p value of 0.05."
        ],
        "rois":[
          {
            "x":882,
            "y":1,
            "x2":1878,
            "y2":2117
          }
        ]
      }
    }
  },
  "1341732":{
    
  },
  "1341734":{
    
  },
  "1343482":{
    "Fig_4.tif":{
      "a":{
        "descriptions":[
          "(a) SPR transmission spectra, normalized to the air spectrum, for different pOBP concentrations in the case of sensor with gold layer with bio-receptor. Inset: Zoom of the resonance wavelengths region. "
        ],
        "rois":[
          {
            "x":5,
            "y":5,
            "x2":1795,
            "y2":961
          }
        ]
      },
      "b":{
        "descriptions":[
          "(b) Resonance wavelength variation as a function of pOBP concentrations [??M]."
        ],
        "rois":[
          {
            "x":299,
            "y":1070,
            "x2":1431,
            "y2":2071
          }
        ]
      }
    }
  },
  "1343484":{
    
  },
  "1343487":{
    "Fig_6.tif":{
      "a":{
        "descriptions":[
          "(a) SPR transmission spectra, normalized to the air spectrum, for different concentration in solution of butanal and with a fixed concentrations of pOBP (1.27 ??M), in the case of sensor with gold layer with bio-receptor. Inset: Zoom of the resonance wavelengths region. "
        ],
        "rois":[
          {
            "x":7,
            "y":7,
            "x2":1894,
            "y2":1030
          }
        ]
      },
      "b":{
        "descriptions":[
          "(b) Resonance wavelength variation as a function of butanal concentration, obtained with binding of a fixed concentration of pOBP in presence of increasing concentration of butanal during pre-incubation time."
        ],
        "rois":[
          {
            "x":236,
            "y":1159,
            "x2":1645,
            "y2":2357
          }
        ]
      }
    }
  },
  "1351060":{
    
  },
  "1352128":{
    "Fig_1.tif":{
      "A":{
        "descriptions":[
          "(A) Construction of the CFA/I/II/IV MEFA. The most antigenic epitopes of the CS1, CS2, CS3, CS4, CS5 and CS6 major structural subunits were embedded into CFA/I major subunit by replacing the CfaB surface-exposed but less antigenic epitopes. "
        ],
        "rois":[
          {
            "x":5,
            "y":5,
            "x2":4094,
            "y2":2413
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Construction of the 3xSTaN12S-dmLT toxoid fusion. Three copies of the STa toxoid STaN12S gene were genetically fused to the monomeric dmLT (LTR192G/L211A) gene using SOE (splicing overlap extension) PCRs. "
        ],
        "rois":[
          
        ]
      },
      "C":{
        "descriptions":[
          "(C) Construction of CFA/I/II/IV-STaN12S-dmLT MEFA. A substitution of the first 150 amino acids of the 3xSTaN12S-dmLT (the N-terminal STaN12S and the first 131 amino acids of LT-A subunit) with the CFA/I/II/IV MEFA created the CFA/I/II/IV-STaN12S-dmLT MEFA. Four linkers: LGA, GPVD, Gly-Pro linker GPGP, and L-linker were used for the construction. "
        ],
        "rois":[
          {
            "x":5,
            "y":5,
            "x2":4094,
            "y2":2413
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D) Western blot to detect the CFA/I/II/IV-STaN12S-dmLT MEFA protein with anti-CFA/I, anti-CS1, -CS2, -CS3, -CS4, -CS5, and anti-CS6 MAb hybridoma supernatant (1:100; provided by Dr. AM Svennerholm), and rabbit anti-CT (1:3300; Sigma) and anti-STa antiserum (1:3300; provided by Dr. DC Robertson). Extracted MEFA proteins separated in 12% PAGE gel were detected with each anti-adhesin MAb, anti-CT and anti-STa antiserum and IRDye-labeled goat anti-mouse IgG or anti-rabbit IgG (1:5000; LI-COR). Lane (+) indicated the CFA/I/II/IV-STaN12S-dmLT MEFA proteins, whereas lane (-) of extracted total proteins of E. coli BL21 host strain as the negative control. Lane M is the protein marker (in kilo Daltons; Precision Plus Protein pre-stained standards; Bio-Rad)."
        ],
        "rois":[
          {
            "x":290,
            "y":2435,
            "x2":3695,
            "y2":3035
          }
        ]
      }
    }
  },
  "1352296":{
    
  },
  "1352297":{
    
  },
  "1353677":{
    "Fig_4.tif":{
      "D":{
        "descriptions":[
          "(D, E) were added and plates were developed using phosphatase substrates. Optical density "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1999,
            "y2":970
          }
        ]
      },
      "E":{
        "descriptions":[
          "(D, E) were added and plates were developed using phosphatase substrates. Optical density "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1999,
            "y2":970
          }
        ]
      },
      "OD":{
        "descriptions":[
          "(OD) was measured at 405 nm on a Bio-Tek Powerwave XS plate reader."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "1354727":{
    
  },
  "1354731":{
    
  },
  "1355155":{
    "Fig_7.tif":{
      "PD":{
        "descriptions":[
          ": The Annexin A2 expression level was over-expressed by constructing and transfecting expression plasmid. Values are mean??SE, N = 3; *, PD"
        ],
        "rois":[
          {
            "x":717,
            "y":241,
            "x2":1204,
            "y2":812
          }
        ]
      },
      "A":{
        "descriptions":[
          "A2 = Annexin A2; Mock = control group, only empty plasmid transfected; NC = Negative control group, only control siRNA transfected; A2 siRNA = Annexin A2 knockdown group transfected with silence siRNA; A2 over = Annexin A2 overexpression group transfected with Annexin A2 expression plasmid; GAS5 down = lncRNA-GAS5 knockdown group transfected with silence siRNA. A"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":750,
            "y2":1074
          },
          {
            "x":1223,
            "y":0,
            "x2":1720,
            "y2":814
          }
        ]
      },
      "PC":{
        "descriptions":[
          ": The Annexin A2 expression level was knockdowned in HSVSMCs effectively by siRNA. Values are mean??SE, N = 3; *, PC"
        ],
        "rois":[
          {
            "x":717,
            "y":241,
            "x2":1204,
            "y2":812
          }
        ]
      },
      "B":{
        "descriptions":[
          ":Silver stains for protein gels obtained by lncRNA-GAS5 RNA Pulldown. Bio-GAS5 (sense): treatment group; Bio-GAS5 (antisense): control groups; GAS5 (sense): negative control groups. The GAS5- specific-binding protein gels (in Red box) was identified by MALDI-TOF-MS. Results show that Annexin A2 isoform 2 is a direct binding protein to lncRNA-GAS5. N = 2. B"
        ],
        "rois":[
          {
            "x":892,
            "y":1025,
            "x2":1609,
            "y2":1868
          },
          {
            "x":717,
            "y":241,
            "x2":1204,
            "y2":812
          }
        ]
      },
      "P":{
        "descriptions":[
          ": The proliferation abilities of HSVSMCs were reflected indirectly by the OD450 values measured using CCK-8 kit when Annexin A2 and lncRNA-GAS5 expression levels were knockdowned or over-expressed simultaneously in HSVSMCs. Firstly Annexin A2 siRNA or expression plasmid were transfected into the HSVSMCs, six hours later, the cell culture medium were changed and then lncRNA-GAS5 siRNA were transfected into the HSVSMCs. Another 48 hours later, the OD450 values were measured by CCK-8 kit. Values are mean??SE, N = 3; *, P"
        ],
        "rois":[
          {
            "x":62,
            "y":1139,
            "x2":712,
            "y2":1806
          },
          {
            "x":717,
            "y":241,
            "x2":1204,
            "y2":812
          }
        ]
      },
      "PE":{
        "descriptions":[
          ": The proliferation abilities of HSVSMCs were reflected indirectly by the OD450 values measured using CCK-8 kit when Annexin A2 expression level were knockdowned or over-expressed in HSVSMCs. Values are mean??SE, N = 3; *, PE"
        ],
        "rois":[
          
        ]
      }
    }
  },
  "1357703":{
    
  },
  "1359174":{
    
  },
  "1365857":{
    
  },
  "1366422":{
    
  },
  "1366596":{
    
  },
  "1369241":{
    "Fig_7.tif":{
      "a":{
        "descriptions":[
          "(a) and with high VDR expression (score 8) "
        ],
        "rois":[
          
        ]
      },
      "b":{
        "descriptions":[
          "(b). Scale bar 30 ??. "
        ],
        "rois":[
          {
            "x":3,
            "y":2,
            "x2":1350,
            "y2":454
          }
        ]
      },
      "c":{
        "descriptions":[
          "(c) The MCA graph demonstrated that phenotype AA is located in the quadrant containing the most aggressive parameters (T3 tumours, HER2 positive, ER negative and G3 in contrast to phenotype GG which is associated to more favorable bio-pathological parameters [T1 tumours, N0, G1, ki67 (-)]."
        ],
        "rois":[
          {
            "x":339,
            "y":509,
            "x2":969,
            "y2":1029
          }
        ]
      }
    }
  },
  "1372804":{
    "Fig_1.tif":{
      "1":{
        "descriptions":[
          "(1) and ~28 kDa "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2149,
            "y2":1374
          }
        ]
      },
      "2":{
        "descriptions":[
          "(2) were chosen for subsequent N-terminal sequencing. B. Limited proteolysis of PBX1 with trypsin. Lane M, Bio-Rad size standard; band 3 is the proteolysis fragment chosen for mass spectrometry analysis. C and D. Identification of PREP1 and PBX1 fragments by MALDI-TOF mass spectrometry analysis. Peptides of PREP1 and PBX1 were identified by MALDI-TOF analysis after digestion of fragments 1???3 with trypsin. Fragment 1 contained PREP1 and the matching peptides (red) covered 52.5% starting from the N-terminus and ending at residue 344. Fragment 2 contains the N-terminal part of PREP1 excluding the homeodomain. Fragment 3 contains PBX1, and the peptides (blue) covered 40.2% of the sequence, from residue 7 to 308."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2149,
            "y2":1374
          }
        ]
      }
    }
  },
  "1372807":{
    "Fig_2.tif":{
      "E":{
        "descriptions":[
          ". E. Co-expression and purification of GST-PBX11???430PREP11???436. Lane M, Bio-Rad size standard; Lane 1, total lysate before IPTG induction; Lane 2, total lysate after IPTG induction; Lane 3, pellet; Lane 4, cleared lysate; Lane 5, flow-through after incubation with glutathione beads; Lane 6, first wash (Tris-buffer with 0.5 M NaCl); Lane 7, second wash (Tris-buffer with 0.3 M NaCl); Lane 8, third wash (Tris-buffer with 0.3 M NaCl); Lane 9, glutathione beads before elution; Lane 10, glutathione beads after elution; Lane 11, supernatant containing the eluted proteins."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1849,
            "y2":1702
          }
        ]
      },
      "A":{
        "descriptions":[
          "A. Expression and purification of full-length PREP1. SDS PAGE analysis of proteins at different purification stages. Lane M, Bio-Rad size standard; Lane 1, total lysate before IPTG induction; Lane 2, total lysate after IPTG induction; Lane 3, pellet; Lane 4, cleared lysate; Lane 5,empty; Lane 6, first wash after incubation with glutathione beads (Tris-buffer with 0.5 M NaCl); Lane 7, second wash (Tris-buffer with 0.3 M NaCl); Lane 8, third wash (Tris-buffer with 0.3 M NaCl); Lane 9, glutathione beads before elution; Lane 10; glutathione beads after elution; Lane 11, supernatant from glutathione beads, containing the eluted protein"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1849,
            "y2":1702
          }
        ]
      },
      "B":{
        "descriptions":[
          ". B. Expression and purification of full-length PBX1. Lane M, Bio-Rad size standard; Lane 1, total lysate before IPTG induction; Lane 2, total lysate after IPTG induction; Lane 3, cleared lysate; Lane 4, flow-through after incubation with glutathione beads; Lane 5, first wash (Tris-buffer with 0.5 M NaCl); Lane 6, second wash (Tris-buffer with 0.3 M NaCl); Lane 7, glutathione beads before elution; Lane 8; glutathione beads after elution; Lane 9, empty; Lane 10, supernatant from glutathione beads, containing the eluted protein"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1849,
            "y2":1702
          }
        ]
      },
      "C":{
        "descriptions":[
          ". C. Expression and purification of PREP11???344. Lane M, Bio-Rad size standard; Lane 1, total lysate before IPTG induction; Lane 2, total lysate after IPTG induction; Lane 3, cleared lysate; Lane 4, flow-through after incubation with glutathione beads; Lane 5, first wash (Tris-buffer with 0.5 M NaCl); Lane 6, second wash (Tris-buffer with 0.3 M NaCl); Lane 7, third wash (Tris-buffer with 0.3 M NaCl); Lane 8, empty; Lane 9; glutathione beads before elution; Lane 10, glutathione beads after elution; Lane 11, empty; Lane 12, supernatant from glutathione beads, containing the eluted protein"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1849,
            "y2":1702
          }
        ]
      },
      "D":{
        "descriptions":[
          ". D. Expression and purification of PBX11???317. Lane M, Bio-Rad size standard; Lane 1, total lysate before IPTG induction; Lane 2, total lysate after IPTG induction; Lane 3, pellet; Lane 4, cleared lysate; Lane 5, flow-through after incubation with glutathione beads; Lane 6, first wash (Tris-buffer with 0.5 M NaCl); Lane 7, second wash (Tris-buffer with 0.3 M NaCl); lane 8, third wash (Tris-buffer with 0.3 M NaCl); Lane 9, glutathione beads before elution; Lane 10, glutathione beads after elution; Lane 11, empty; Lane 12, supernatant from glutathione beads, containing the eluted protein"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1849,
            "y2":1702
          }
        ]
      }
    }
  },
  "1372808":{
    "Fig_3.tif":{
      "A":{
        "descriptions":[
          "A. Co-expressed and purified full-length PBX1:PREP1 complex was loaded onto a Res Q anion exchange column and eluted with a 0.1???1 M NaCl gradient"
        ],
        "rois":[
          {
            "x":3,
            "y":5,
            "x2":1657,
            "y2":1066
          }
        ]
      },
      "B":{
        "descriptions":[
          ". B. SDS PAGE of fractions from anion exchange of full-length PBX1:PREP1. Lane M, Bio-Rad size standard; lanes 1???13, fractions indicated in cyan in the above chromatogram; fraction volume was 1.5 ml, and on SDS PAGE were loaded 10 ??l of each fraction C. SDS PAGE of fractions from anion exchange column of PBX11???308:PREP11???344. Lane M, Bio-Rad size standard; lanes 1???5, fractions indicated in cyan in the chromatogram below; fraction volume was 1.5 ml, and on SDS PAGE were loaded 10 ??l of each fraction D. Co-expressed and purified PBX11???308:PREP11???344 complex was loaded onto a Res S cation exchange column and eluted with a 0.1???1 M NaCl gradient."
        ],
        "rois":[
          {
            "x":343,
            "y":723,
            "x2":1996,
            "y2":1975
          },
          {
            "x":3,
            "y":5,
            "x2":1657,
            "y2":1066
          }
        ]
      }
    }
  },
  "1372811":{
    "Fig_4.tif":{
      "A":{
        "descriptions":[
          "A. Size exclusion chromatography on a Superose 6 10/300 column of the full-length PBX1:PREP1 complex purified by anion exchange chromatography. Markers were thyroglobulin (Mr 670,000), bovine gamma globulin (Mr 158,000), chicken ovalbumin (Mr 44,000), equine myoglobin (Mr 17,000), and vitamin B12 (Mr 1,350)"
        ],
        "rois":[
          {
            "x":3,
            "y":4,
            "x2":1897,
            "y2":1835
          }
        ]
      },
      "B":{
        "descriptions":[
          ". B. SDS PAGE of fractions from full-length PBX1:PREP1 gel filtration. Lane M, Bio-Rad size standard; lanes 1???7, fractions indicated in cyan in the above chromatogram; fractions volume was 0.5 ml, and on SDS PAGE were loaded 10 ??l of each fraction C. SDS PAGE of fractions from PBX1 1???308:PREP1 1???344 gel filtration. Lane M, Bio-Rad size standard; lanes 1???7, fractions indicated in cyan in the chromatogram below; fractions volume was 0.5 ml, and on SDS PAGE were loaded 10 ??l of each fraction D. Size exclusion chromatography on a Superose 6 10/300 column of the truncated PBX11???308:PREP11???344 complex purified by cation exchange chromatography. Markers were as in panel A."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "1374292":{
    "Fig_4.tif":{
      "E":{
        "descriptions":[
          "(E) GSK3?? binds Dzip1 in a kinase-substrate interaction manner. Wild-type "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2240,
            "y2":2114
          }
        ]
      },
      "F":{
        "descriptions":[
          "(F) Phosphorylation of Dzip1 is coordinated with GSK3?? activation. The kinase activity of GSK3?? was negatively correlated with serum stimulation in NIH 3T3 cells. Note that the up-shifted bands (arrowheads) of Dzip1 became evident after serum depletion for 24???48 h, and disappeared after serum restimulation. ??-Tubulin was set as a loading control. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2240,
            "y2":2114
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A), and endogenous Dzip1 was immunoprecipitated with GFP-GSK3?? in HEK 293T cells "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2240,
            "y2":2114
          }
        ]
      },
      "WT":{
        "descriptions":[
          "(WT) GFP-GSK3?? and the mutants S9A, K85R, and R96A were each co-expressed with Myc-Dzip1 in G0-phase HEK 293T cells, and treated with the CK1 inhibitor D4476 or the CK2 inhibitor CX4945. Note that treatment with CX4945 but not D4476 led to a significant decrease in the extent of the up-shifted Dzip1 bands, although the binding of Dzip1 to the GFP-GSK3?? variants showed no difference. The extent of the up-shifting of the Dzip1 bands was decreased in K85R-expressing cells. "
        ],
        "rois":[
          
        ]
      },
      "I":{
        "descriptions":[
          "(I) Inhibition of GSK3 by BIO causes loss of phospho-S520 in Dzip1."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2240,
            "y2":2114
          }
        ]
      },
      "G":{
        "descriptions":[
          "(G) GSK3?? phosphorylates Dzip1 in vivo. In resting mouse embryo fibroblast (MEFs) treated versus not treated with GSK3 and CK2 inhibitors, the Dzip1 bands were up-shifted less in GSK3- and CK2-inhibited cells. The protein levels of total ??-Catenin and GSK3?? were steady, but the phosphorylated (S33/37/T41) ??-Catenin specifically disappeared from GSK3-inhibited cells. ??-Tubulin was set as a loading control. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2240,
            "y2":2114
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B). (C and D) Dzip1 is co-localized with GSK3?? at the basal body. G0-phase NIH 3T3 cells expressing GFP-GSK3?? were immunostained for Dzip1 and AcTub "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2240,
            "y2":2114
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C), or cells expressing BFP-Centrin2 were immunostained with GSK3?? and Dzip1 "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2240,
            "y2":2114
          }
        ]
      },
      "H":{
        "descriptions":[
          "(H) GSK3?? phosphorylates Dzip1 in vitro. Auto-phosphorylation of GSK3?? (55 kD), and the phosphorylated bands of the middle (28 kD), C-terminus (36 kD), and N- terminus (50 kD) of Dzip1 are shown (left panel). Coomassie blue staining of the gel shows the loaded amounts of Dzip1 fragments (right panel). Note that the S520A mutation resulted in decreased phosphorylation of Dzip1 by GSK3??. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2240,
            "y2":2114
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D). Scale bar: 5 ??m. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2240,
            "y2":2114
          }
        ]
      }
    }
  },
  "1374294":{
    "Fig_5.tif":{
      "E":{
        "descriptions":[
          "(E). "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2177,
            "y2":2493
          }
        ]
      },
      "F":{
        "descriptions":[
          "(F) Expression of Dzip1S520A leads to increased binding of Rab8 to GDI2. The GFP-Dzip1 mutants and endogenous Rab8 were pulled down from G0-phase HEK 293T cells by increasing amounts of GST-GDI2. The maximum amounts of the pulled-down proteins were defined as having a binding affinity of 1.0, and the amounts of the indicated proteins at each point were normalized to the maximum amounts. The results represent two independent assays. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2177,
            "y2":2493
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) The binding of Dzip1 with GDI2 is prevented by inhibition of GSK3. G0-phase NIH 3T3 cells were treated or not treated with the GSK3 inhibitor BIO, and endogenous Dzip1 and GDI2 were analyzed. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2177,
            "y2":2493
          }
        ]
      },
      "WT":{
        "descriptions":[
          "(WT) GFP-Dzip1 or S520 mutants were co-expressed with Myc-GDI2 in G0-phase HEK 293T cells, followed by IP assay. White asterisks indicate the heavy chain of IgG."
        ],
        "rois":[
          
        ]
      },
      "G":{
        "descriptions":[
          "(G) Phosphorylation of Dzip1S520 increases its binding to GDI2. GFP alone or wild-type "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2177,
            "y2":2493
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) The binding of Rab8GDP with GDI2 is increased by inhibition of GSK3. G0-phase HEK 293T cells expressing GFP-Rab8T22N were treated or not treated with the GSK3 inhibitors BIO or CHIR99021 (CHIR), and endogenous GDI2 was analyzed. The quantified band intensities are labeled. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2177,
            "y2":2493
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) The binding of GDI2 to Dzip1 is decreased, but to Rab8 is increased, by inhibition of GSK3. Endogenous Dzip1 and Rab8 were pulled down from G0-phase NIH 3T3 cells treated with the GSK3 inhibitor or from control (Con) cells by increasing amounts of GST-GDI2. The maximum amounts of the pulled-down proteins were defined as having a binding affinity of 1.0, and the amounts of the indicated proteins at each point were normalized to the maximum amounts. The results represent two independent assays. (D and E) The amount of free Rab8GDP at the basal body is decreased by inhibition of GSK3. G0-phase NIH 3T3 cells expressing the fusion protein CFP-RBD-YFP were treated with the GSK3 inhibitors BIO or CHIR99021 or not treated (control). The values shown are mean ?? SD, from 20 cells for each group "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2177,
            "y2":2493
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D). The calculated region was manually selected at the cilium base based on strong accumulation of the CFP-RBD-YFP signal. *p CFP distributions in quantitative analysis. The FECFP was highest around the basal body (labeled by AcTub staining) in the control cell, but was largely eliminated in GSK3-inhibited cells. The rainbow indicator in the heat map shows the FECFP, and each colored dot in the image represents the appearance of FECFP. The red boxes indicate the areas selected for calibrating background "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2177,
            "y2":2493
          }
        ]
      }
    }
  },
  "1374297":{
    "Fig_6.tif":{
      "E":{
        "descriptions":[
          "(E). (F and G) The kinase activity of GSK3?? is required for ciliogenesis. GSK3?????/??? MEFs were transfected with wild-type GFP-GSK3?? or mutant GFP-GSK3?? S9A, K85R, or R96A and immunostained with AcTub. The DNA was stained with DAPI. Representative images are shown in ",
          "(E), "
        ],
        "rois":[
          {
            "x":488,
            "y":938,
            "x2":610,
            "y2":1060
          },
          {
            "x":1665,
            "y":872,
            "x2":2214,
            "y2":1393
          },
          {
            "x":1473,
            "y":938,
            "x2":1595,
            "y2":1060
          }
        ]
      },
      "F":{
        "descriptions":[
          "(F), and the percentage ciliation ratios are shown in "
        ],
        "rois":[
          {
            "x":4,
            "y":1397,
            "x2":485,
            "y2":1829
          },
          {
            "x":488,
            "y":938,
            "x2":610,
            "y2":1060
          },
          {
            "x":1473,
            "y":938,
            "x2":1595,
            "y2":1060
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) Schematic model of the acquisition of synchronized mitosis???G0 phase NIH 3T3 cells, treated with double thymidine block, nocodazole (Noc), and the indicated GSK3 inhibitors. (B and C) Inhibition of GSK3 impairs ciliogenesis. Representative images of ciliated cells during the mitosis???G0 phase transition without (Con) or with BIO or CHIR99021 treatment. Cells were immunostained for ??-Tubulin and AcTub. The DNA was stained with DAPI. Ciliation ratios for "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2216,
            "y2":791
          }
        ]
      },
      "WT":{
        "descriptions":[
          "(WT), GSK3?????/???, and GSK3?????/??? MEFs during the mitosis???G0 phase transition were immunostained with ??-Tubulin and AcTub. The DNA was stained with DAPI. Ciliation percentage ratios for "
        ],
        "rois":[
          {
            "x":4,
            "y":1397,
            "x2":485,
            "y2":1829
          }
        ]
      },
      "I":{
        "descriptions":[
          "(I). The values in ",
          "(I) are mean ?? SD; 50 pairs of daughter cells were counted in each of three independent experiments. ***p "
        ],
        "rois":[
          {
            "x":488,
            "y":1061,
            "x2":610,
            "y2":2076
          },
          {
            "x":615,
            "y":1893,
            "x2":978,
            "y2":2317
          },
          {
            "x":616,
            "y":877,
            "x2":1101,
            "y2":1302
          },
          {
            "x":616,
            "y":1402,
            "x2":1101,
            "y2":1830
          },
          {
            "x":980,
            "y":1181,
            "x2":1101,
            "y2":1302
          },
          {
            "x":1664,
            "y":1888,
            "x2":2214,
            "y2":2360
          },
          {
            "x":1107,
            "y":1893,
            "x2":1470,
            "y2":2317
          },
          {
            "x":1473,
            "y":938,
            "x2":1595,
            "y2":1060
          },
          {
            "x":1473,
            "y":1181,
            "x2":1595,
            "y2":1830
          },
          {
            "x":0,
            "y":0,
            "x2":2216,
            "y2":791
          }
        ]
      },
      "G":{
        "descriptions":[
          "(G). Note that the wild-type and S9A fully, and R96A partially, rescued the ciliogenesis defect, whereas K85R did not. (H and I) A phosphorylation-mimicking mutant of Dzip1 rescues the ciliogenesis defect in GSK3?????/??? cells. GSK3?????/??? MEFs were transfected with wild-type Myc-Dzip1, mutant S520A, or S520D, and immunostained with AcTub. The DNA was stained with DAPI. Representative images are shown in ",
          "(G), and "
        ],
        "rois":[
          {
            "x":488,
            "y":938,
            "x2":610,
            "y2":1060
          },
          {
            "x":616,
            "y":877,
            "x2":1101,
            "y2":1302
          },
          {
            "x":1662,
            "y":1383,
            "x2":2214,
            "y2":1850
          },
          {
            "x":1108,
            "y":1402,
            "x2":1471,
            "y2":1830
          },
          {
            "x":1473,
            "y":938,
            "x2":1595,
            "y2":1060
          },
          {
            "x":1473,
            "y":1061,
            "x2":1595,
            "y2":1180
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) are shown in "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2216,
            "y2":791
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C). (D and E) Knockout ",
          "(C), "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2216,
            "y2":791
          }
        ]
      },
      "H":{
        "descriptions":[
          "(H), and the percentage ciliation ratios are shown in "
        ],
        "rois":[
          {
            "x":4,
            "y":1888,
            "x2":485,
            "y2":2317
          },
          {
            "x":616,
            "y":877,
            "x2":1101,
            "y2":1302
          },
          {
            "x":980,
            "y":1061,
            "x2":1101,
            "y2":1180
          },
          {
            "x":1473,
            "y":938,
            "x2":1595,
            "y2":1060
          }
        ]
      },
      "KO":{
        "descriptions":[
          "(KO) of GSK3??, but not GSK3??, abolishes ciliogenesis. Wild-type "
        ],
        "rois":[
          {
            "x":488,
            "y":2077,
            "x2":610,
            "y2":2317
          },
          {
            "x":1473,
            "y":2196,
            "x2":1592,
            "y2":2317
          },
          {
            "x":980,
            "y":1954,
            "x2":1592,
            "y2":2317
          },
          {
            "x":1110,
            "y":877,
            "x2":1471,
            "y2":1302
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D) are shown in "
        ],
        "rois":[
          {
            "x":3,
            "y":872,
            "x2":485,
            "y2":1302
          }
        ]
      }
    }
  },
  "1376556":{
    "Fig_1.tif":{
      "13":{
        "descriptions":[
          "[13,34], except for microtubule-binding of Z555??N (*), which is based on results described below. CC1, CC2: coiled coil predicted with high and low propensity, respectively; C1: C1 domain; RhoGAP: Rho-family GTPase-activating protein domain; Kinesin: kinesin motor domain; ARFB: ARF6-binding domain "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":4156,
            "y2":4016
          }
        ]
      },
      "34":{
        "descriptions":[
          "[13,34], except for microtubule-binding of Z555??N (*), which is based on results described below. CC1, CC2: coiled coil predicted with high and low propensity, respectively; C1: C1 domain; RhoGAP: Rho-family GTPase-activating protein domain; Kinesin: kinesin motor domain; ARFB: ARF6-binding domain "
        ],
        "rois":[
          
        ]
      },
      "9":{
        "descriptions":[
          "[9,10], BIO: 20 aa biotinylation tag. (B???E) Protein preparations used in this study were run on SDS-PAGE gels and visualized with Coomassie stain. Note that the version of Z601 used in Z601/C120, which lacks the biotinylation tag, showed a slightly larger mobility than those used alone or in a complex with C40G."
        ],
        "rois":[
          
        ]
      },
      "10":{
        "descriptions":[
          "[9,10], BIO: 20 aa biotinylation tag. (B???E) Protein preparations used in this study were run on SDS-PAGE gels and visualized with Coomassie stain. Note that the version of Z601 used in Z601/C120, which lacks the biotinylation tag, showed a slightly larger mobility than those used alone or in a complex with C40G."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":4156,
            "y2":4016
          }
        ]
      }
    }
  },
  "1381576":{
    "Fig_2.tif":{
      "A":{
        "descriptions":[
          "A: analysis of amplification products obtained from qRT-PCR reactions with template (cDNA) amounts of 100 ng, 10 ng, 1 ng and 0.1 ng by agarose gel electrophoresis. The efficiency of the primer pair ???pomB fwd??? / ???pomB rev??? was 115% with R2 = 0.998, as calculated using the CFX Manager software (Bio-Rad). A 100 bp DNA ladder (GeneRuler, Thermo Scientific) served as molecular size marker"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2499,
            "y2":3183
          }
        ]
      },
      "B":{
        "descriptions":[
          ". B: The correct size (134 bp) of the products from the qRT-PCR reactions (technical triplicates, I???III) was confirmed by agarose gel electrophoresis"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2499,
            "y2":3183
          }
        ]
      },
      "C":{
        "descriptions":[
          ". C: Relative transcription level of pomB in the V. cholerae reference strain and in V. cholerae ??pomAB pAB induced with 10 mM L-arabinose. For both strains, qRT-PCR reactions were performed in technical triplicates. Transcription levels of pomB were calculated using the CFX Manager software (Bio-Rad, version 2.1.1022.0523), and the transcription level of the chromosomally encoded pomB (reference strain) was set to 1."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "1382275":{
    "Fig_3.tif":{
      "A":{
        "descriptions":[
          "A) PAX3 protein levels relative to ??-actin. Each sample was run in duplicate on separate gels and the density of each band was assessed by densitometric scanning using the GS-800 Calibrated Densitometer (Bio-Rad). The density of each PAX3 band was compared to that of ??-actin for each lane on the same membrane and the fold change calculated and graphed. The error bars represent the standard deviation between duplicate samples"
        ],
        "rois":[
          {
            "x":4,
            "y":25,
            "x2":1087,
            "y2":900
          }
        ]
      },
      "I":{
        "descriptions":[
          "(I)) human epidermal melanocytes as well as six primary (MM200, MM229, MM329, MM540, MM622 and WM115) and five metastatic (A2058, M14, SKMEL2, SKMEL5 and UACC62) melanoma cell lines. The level of PAX3 expression was calculated as fold-change relative to GAPDH expression levels. All PCRs were performed in triplicate and average values were used to calculate fold change over GAPDH for each sample. All samples were run in biological duplicates and the error bars represent the standard deviation of the biological replicates"
        ],
        "rois":[
          {
            "x":1152,
            "y":1263,
            "x2":1448,
            "y2":1501
          },
          {
            "x":1152,
            "y":1019,
            "x2":1747,
            "y2":1501
          }
        ]
      },
      "B":{
        "descriptions":[
          ". B) PAX3 mRNA expression in neonatal and adult normal human epidermal melanocytes and primary and metastatic melanoma cell lines. RT-qPCR was performed using RNA from neonatal (NHEM-n) and adult (NHEM-a "
        ],
        "rois":[
          {
            "x":4,
            "y":25,
            "x2":1087,
            "y2":900
          }
        ]
      },
      "P":{
        "descriptions":[
          "(P) and NHEM-a "
        ],
        "rois":[
          {
            "x":1152,
            "y":1507,
            "x2":1747,
            "y2":1747
          }
        ]
      },
      "C":{
        "descriptions":[
          ". C) Immunocytochemistry of neonatal and adult human epidermal melanocytes, five metastatic melanoma cell lines and six primary melanoma cell lines. Nuclear PAX3 protein expression (red) is observed in all melanoma cell lines and primary melanocytes. Cell nuclei are stained with DAPI (blue). The scale measures 100 ??M. A negative control was included with each experimental run and proved negative in each instance."
        ],
        "rois":[
          {
            "x":60,
            "y":945,
            "x2":1086,
            "y2":1770
          },
          {
            "x":1453,
            "y":1019,
            "x2":1747,
            "y2":1258
          },
          {
            "x":1103,
            "y":4,
            "x2":1747,
            "y2":243
          },
          {
            "x":1152,
            "y":265,
            "x2":1747,
            "y2":996
          }
        ]
      }
    }
  },
  "1385587":{
    "Fig_1.tif":{
      "A":{
        "descriptions":[
          "(A) Top panel???Profiles of total extracellular protein (ECP) from P. aeruginosa PAO1 WT and morA KO culture supernatants. Samples were loaded based on protein secreted from equal number of cells. Protein bands were identified by MALDI-ToF-ToF. Bottom panel???Immunoblot of RNA polymerase (loading control) from cellular fractions of respective cultures. L-Protein ladder (Bio-Rad). "
        ],
        "rois":[
          {
            "x":11,
            "y":11,
            "x2":1728,
            "y2":1962
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Percentage increase in levels of secreted proteins in morA KO compared to WT. Error bars represent mean +SE (n = 3). Student???s t-test, p-value"
        ],
        "rois":[
          {
            "x":11,
            "y":11,
            "x2":1728,
            "y2":1962
          },
          {
            "x":1790,
            "y":141,
            "x2":4007,
            "y2":1981
          }
        ]
      }
    }
  },
  "1385589":{
    "Fig_2.tif":{
      "A":{
        "descriptions":[
          "(A) Top panel???Total extracellular protein (ECP) from culture supernatants of P. aeruginosa strains loaded based on protein secreted from equal number of cells. Black arrow indicates the position of elastase (LasB) band. Bottom panel???Immunoblot of RNA polymerase (loading control) on cellular fractions of respective cultures in top panel. L-Ladder (Bio-Rad). "
        ],
        "rois":[
          {
            "x":10,
            "y":11,
            "x2":2355,
            "y2":1853
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Percentage increase in levels of secreted LasB based on protein band quantification by densitometry. Band intensity values of MorA insertion (morA KO) and deletion (??morA) mutants are compared with wildtype "
        ],
        "rois":[
          {
            "x":10,
            "y":11,
            "x2":2355,
            "y2":1853
          }
        ]
      },
      "WT":{
        "descriptions":[
          "(WT) while those of strains expressing MorA with mutations in GGDEF and EAL motifs (represented as ??morA???pUG* and ??morA???pUE* respectively) are compared with complementation strain (??morA-pU) containing full length morA expressed in ??morA background. Error bars represent mean +SE (n = 5). Student???s t-test, p-value"
        ],
        "rois":[
          {
            "x":2369,
            "y":150,
            "x2":4011,
            "y2":1611
          }
        ]
      }
    }
  },
  "1386166":{
    
  },
  "139390":{
    "Figure_S1.tif":{
      "i":{
        "descriptions":[
          "(i) rationally design microbial biosensors for chemicals of interest based on substrate auxotrophy that would enable their high-throughput screening; "
        ],
        "rois":[
          {
            "x":1282,
            "y":28,
            "x2":2277,
            "y2":999
          }
        ]
      },
      "ii":{
        "descriptions":[
          "(ii) predict engineering strategies for coupling the synthesis of a chemical of interest with the production of a proxy metabolite for which high-throughput screening is possible via a designed bio-sensor. The biosensor design method is validated based on known genetic modifications in an array of E. coli strains auxotrophic to various amino-acids. Predicted chemical production rates achievable via the biosensor-based approach are shown to potentially improve upon those predicted by current rational strain design approaches. (A Matlab implementation of the biosensor design method is available via http://www.cs.technion.ac.il/~tomersh/tools). "
        ],
        "rois":[
          {
            "x":30,
            "y":28,
            "x2":1052,
            "y2":999
          }
        ]
      }
    }
  },
  "1395036":{
    
  },
  "1395038":{
    "Fig_5.tif":{
      "A":{
        "descriptions":[
          "(A) nanoparticle-streptavidin, "
        ],
        "rois":[
          {
            "x":10,
            "y":10,
            "x2":989,
            "y2":847
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) bio-TurboNuclease, "
        ],
        "rois":[
          {
            "x":1127,
            "y":10,
            "x2":2090,
            "y2":843
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) FLOS and "
        ],
        "rois":[
          {
            "x":11,
            "y":945,
            "x2":1019,
            "y2":1810
          },
          {
            "x":1127,
            "y":10,
            "x2":2090,
            "y2":843
          }
        ]
      },
      "NC":{
        "descriptions":[
          "(NC) contained all components except what was to be optimized. Each of the component was analyzed in five repeats and were performed in two independent experiments. Means ?? SD are shown."
        ],
        "rois":[
          
        ]
      },
      "D":{
        "descriptions":[
          "(D) diameters of the nanoparticles. Both nanoparticle-streptavidin and bio-TurboNuclease were prepared at 1:10 serial dilutions between 10???8 -10-13 M. The FLOS oligos were prepared at 1:2 serial dilutions between 400???3.1 ??10???8 M. Four different diameter sizes (13, 30, 40 and 50 nm) were analyzed for nanoparticles. Negative control "
        ],
        "rois":[
          {
            "x":1127,
            "y":10,
            "x2":2090,
            "y2":843
          },
          {
            "x":1118,
            "y":946,
            "x2":2083,
            "y2":1814
          }
        ]
      }
    }
  },
  "1396639":{
    
  },
  "1397740":{
    "Fig_1.tif":{
      "A":{
        "descriptions":[
          "(A) Modular domain structure of LuxR-type regulators, with a N-terminal signal-binding domain (SBD) and a C-terminal DNA-binding domain (DBD) [8], containing the helix-turn-helix \"HTH LUXR\" motif (SMART00421) [25]. "
        ],
        "rois":[
          {
            "x":0,
            "y":17,
            "x2":865,
            "y2":432
          },
          {
            "x":80,
            "y":1039,
            "x2":2221,
            "y2":1622
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Comparison of the protein sequence identity of PluR from P. luminescens, PauR from P. asymbiotica and TraR from A. tumefaciens. The identity was compared either of the full-length protein sequence, only the signal-binding domain (SBD) and only the DNA-binding domain (DBD). To calculate identity of the protein sequences the LALIGN software from SIB (Swiss Institute of Bioinformatics) was used [26]. "
        ],
        "rois":[
          {
            "x":970,
            "y":0,
            "x2":2085,
            "y2":653
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Sequence alignment of the protein sequences of PauR from P. asymbiotica (P.a.), PluR from P. luminescens (P.l.), QscR from Pseudomonas aeruginosa (P.a.), SdiA from Escherichia coli (E.c.), TraR from Agrobacterium tumefaciens (A.t.) and LuxR from Vibrio fischeri (V.f.). The SBD is depicted with a blue bar and the DBD with a green bar. Within the SBD the six conserved amino acids, displaying the WYDPWG-motif of AHL-sensors, are marked with red asterisks and the three conserved amino acids in the DBD are marked with blue asterisks. Amino acids with a consensus of 60???100% are shown, positions with a lower coverage are marked with a dot. The RasMol colouring of the amino acids and the alignment was generated with CLC Mainworkbench 7 (CLC Bio Qiagen, Hilden, Germany)."
        ],
        "rois":[
          {
            "x":1,
            "y":737,
            "x2":2205,
            "y2":1046
          }
        ]
      }
    }
  },
  "1398279":{
    
  },
  "1399683":{
    "Fig_7.tif":{
      "e":{
        "descriptions":[
          "(e) Bar graphs showing the averaged values of 46 probes of Integrin members, 24 probes of Laminins, 8 probes of cytokines and 8 probes of receptors of cytokines extracted from normalized microarray data of CD34+CD38- double-selected TF-1a cells treated as in A. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1499,
            "y2":2441
          }
        ]
      },
      "j":{
        "descriptions":[
          "(j) conducted on TF-1a cells treated with D9 (100 nM), SAHA (100 nM) or DAC (100 nM) with or without Ara-C (100 nM). Data are mean ?? SEM; N = 3; *P "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1499,
            "y2":2441
          }
        ]
      },
      "f":{
        "descriptions":[
          "(f) Bar graphs showing qRT-PCR validation of microarray expression data of 15 representative genes as indicated. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1499,
            "y2":2441
          }
        ]
      },
      "a":{
        "descriptions":[
          "(a) Heat map of 720 genesets induced by both Ara-C and ADR which were suppressed by D9. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1499,
            "y2":2441
          }
        ]
      },
      "i":{
        "descriptions":[
          "(i) and adhesion assay "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1499,
            "y2":2441
          }
        ]
      },
      "b":{
        "descriptions":[
          "(b) The diagram showing the top five Bio Functions of commonly upregulated 720 genes by Ara-C and ADR suggested by IPA. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1499,
            "y2":2441
          }
        ]
      },
      "g":{
        "descriptions":[
          "(g) Representative phase-contrast images of TF-1a cells treated with D9 (100 nM), Ara-C (50 nM) alone or combination. Bar graphs showing transwell migration assay "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1499,
            "y2":2441
          }
        ]
      },
      "c":{
        "descriptions":[
          "(c) The diagram showing the top ten canonical pathways of commonly upregulated 720 genes by Ara-C and ADR suggested by IPA. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1499,
            "y2":2441
          }
        ]
      },
      "h":{
        "descriptions":[
          "(h), invasion assays "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1499,
            "y2":2441
          }
        ]
      },
      "d":{
        "descriptions":[
          "(d) The diagrams showing Integrins and AKT are highly associated networks of commonly upregulated 720 genes by Ara-C and ADR suggested by IPA. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1499,
            "y2":2441
          }
        ]
      }
    }
  },
  "1402606":{
    "Fig_7.tif":{
      "IL":{
        "descriptions":[
          ": IL: interleukin"
        ],
        "rois":[
          
        ]
      },
      "KC":{
        "descriptions":[
          ", KC: keratinocyte chemoattractant, G-CSF: granulocyte-colony stimulating factor, IFN??: interferon gamma, TNF??: tumor necrosis factor alpha, MCP-1 (CCL2): monocyte chemoattractant protein-1 (CCL3 or 4), MIP: macrophage inflammatory protein, RANTES (CCL5): regulated on activation, normal T cell expressed and secreted, GM-CSF: granulocyte/macrophage-colony stimulating factor. * P"
        ],
        "rois":[
          {
            "x":278,
            "y":2144,
            "x2":1417,
            "y2":2541
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) and chemokines "
        ],
        "rois":[
          {
            "x":26,
            "y":1,
            "x2":1632,
            "y2":1573
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) were quantified from a panel of 23 cytokines using a multiplex bead assay (Bio-Rad, Hercules"
        ],
        "rois":[
          {
            "x":0,
            "y":1636,
            "x2":477,
            "y2":2086
          }
        ]
      },
      "CA":{
        "descriptions":[
          ", CA) following the manufacturer???s protocols. Results shown are pooled from two separate experiments Cytokine abbreviations are as follows"
        ],
        "rois":[
          {
            "x":555,
            "y":1697,
            "x2":1594,
            "y2":2093
          }
        ]
      }
    }
  },
  "1406012":{
    
  },
  "1408103":{
    
  },
  "140877":{
    "Figure_S1.tif":{
      "4":{
        "descriptions":[
          "(4) and coelonin "
        ],
        "rois":[
          
        ]
      },
      "5":{
        "descriptions":[
          "(5). Stilbenoids (1???3) were the most concentrated in crude hydro-alcoholic stem extract and were considered as Vanda coerulea stem biomarkers. Dihydro-phenanthropyran "
        ],
        "rois":[
          {
            "x":129,
            "y":147,
            "x2":3247,
            "y2":2552
          }
        ]
      },
      "1":{
        "descriptions":[
          "(1) methoxycoelonin ",
          "(1) and dihydro-phenanthrene ",
          "(1) and ",
          "(1) and ",
          "(1) and methoxycoelonin "
        ],
        "rois":[
          {
            "x":129,
            "y":147,
            "x2":3247,
            "y2":2552
          }
        ]
      },
      "2":{
        "descriptions":[
          "(2) gigantol ",
          "(2) displayed the best DPPH/???OH radical scavenging activities as well as HaCaT intracellular antioxidant properties (using DCFH-DA probe: IC50 8.8 ??M and 9.4 ??M, respectively) compared to bibenzyle ",
          "(2) (IC50 12.2 ??M and 19.3 ??M, respectively). Western blot analysis revealed that stilbenoids (1???3) inhibited COX-2 expression at 23 ??M. Interestingly, stilbenoids ",
          "(2) but not ",
          "(2) were also able to inhibit COX-2 activity in a concentration-dependent manner thereby reducing PGE-2 production from irradiated HaCaT cells. Our studies suggest that stilbenoids (1???3) could be potentially used for skin protection against the damage caused by UVB exposure."
        ],
        "rois":[
          {
            "x":129,
            "y":147,
            "x2":3247,
            "y2":2552
          }
        ]
      },
      "3":{
        "descriptions":[
          "(3) flavidin ",
          "(3) (IC50 20.6 ??M). In turn, the latter showed a constant inhibition of PGE-2 production, stronger than stilbenoids ",
          "(3) were able to inhibit human recombinant COX-2 activity.ConclusionsMajor antioxidant stilbenoids (1???3) from Vanda coerulea stems displayed an inhibition of UVB-induced COX-2 expression. Imbricatin "
        ],
        "rois":[
          {
            "x":129,
            "y":147,
            "x2":3247,
            "y2":2552
          }
        ]
      }
    }
  },
  "1410578":{
    
  },
  "1413206":{
    
  },
  "1413316":{
    "Fig_6.tif":{
      "A":{
        "descriptions":[
          "(A) Schematic depiction of bio-orthogonal labeling of proteins with alk-16 and an azido-reporter (tag, azido-rhodamine for fluorescence detection or azido-biotin for affinity purification). "
        ],
        "rois":[
          {
            "x":14,
            "y":10,
            "x2":2037,
            "y2":590
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Total proteins from wild-type and mutant cells labeled ?? alk-16, resolved by SDS-PAGE, and analyzed by Coomassie stain or in-gel fluorescence. MW standards (in kDa) are indicated on the right. "
        ],
        "rois":[
          {
            "x":12,
            "y":674,
            "x2":2072,
            "y2":3662
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Localization of Chs3-mCherry expressed in the strain indicated and visualized by fluorescence (left, shown as a negative image for clarity) or brightfield microscopy (right). Scale bar, 5 ??m."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "1415285":{
    "Fig_2.tif":{
      "AO":{
        "descriptions":[
          "[AO]7:GALT5 reaction product before and after base hydroylysis. Permeablized microsomal membranes from the Pichia C5 line expressing 6x His-GALT5 served as the enzyme source in the ",
          "[AO]7:GALT5 reaction. Elution profiles of the reaction product before and after base hydrolysis are shown. The column was calibrated with high-Mr dextran (V0), galactose (Vt), xylo-oligosaccharides with degree of polymerization "
        ],
        "rois":[
          {
            "x":4,
            "y":4,
            "x2":2104,
            "y2":2321
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) Bio-gel P2 fractionation of the RP-HPLC purified "
        ],
        "rois":[
          {
            "x":4,
            "y":4,
            "x2":2104,
            "y2":2321
          }
        ]
      },
      "DP":{
        "descriptions":[
          "(DP) 2 to 5 and xyloglucan-oligosaccharides (DP6-9); their elution positions are indicated with arrows at the top of the figure. The elution position of free Hyp amino acid (corresponding to DP3) is shown with an arrow in the panel. Base hydrolysis produces a radioactive peak eluting at DP4, which corresponds to Hyp-Gal. "
        ],
        "rois":[
          
        ]
      },
      "B":{
        "descriptions":[
          "(B) HPAEC profile of a chemically synthesized Hyp-Gal standard detected as a PAD response. "
        ],
        "rois":[
          {
            "x":4,
            "y":4,
            "x2":2104,
            "y2":2321
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) The radioactive peak eluting at DP4 coelutes with the chemically synthesized Hyp-Gal standard following HPAEC. Both the Hyp-Gal standard and the radioactive peak eluting at DP4 were fractionated in 5 mM NaOH elution buffer on a CarboPac PA-20 column."
        ],
        "rois":[
          {
            "x":4,
            "y":4,
            "x2":2104,
            "y2":2321
          }
        ]
      }
    }
  },
  "14167":{
    
  },
  "1421649":{
    "Fig_1.tif":{
      "E":{
        "descriptions":[
          "(E) PLS-DA plot of ERIC-PCR data from fecal microbiota of nonxenograft and xenograft nude mice at Day 10. Black square: nonxenograft nude mice; Red dot: xenograft nude mice. "
        ],
        "rois":[
          {
            "x":23,
            "y":1901,
            "x2":895,
            "y2":2568
          }
        ]
      },
      "F":{
        "descriptions":[
          "(F) Correlation coefficients of fecal microbiota of nonxenograft and xenograft nude mice. All data were expressed as the percentage change over the Day 0 control of each mouse, and presented as the mean ?? SEM (* P "
        ],
        "rois":[
          {
            "x":894,
            "y":1901,
            "x2":1812,
            "y2":2529
          },
          {
            "x":150,
            "y":717,
            "x2":1595,
            "y2":1399
          },
          {
            "x":979,
            "y":49,
            "x2":1798,
            "y2":665
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) Tumor growth curve. "
        ],
        "rois":[
          {
            "x":3,
            "y":23,
            "x2":1788,
            "y2":1852
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Body wight. "
        ],
        "rois":[
          {
            "x":3,
            "y":23,
            "x2":1788,
            "y2":1852
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Representative ERIC-PCR DNA fingerprints of the fecal microbiota of individual nonxenograft and xenograft nude mice. Fecal samples were collected before xenograft (Day 0), and 5 & 10 d upon saline or tumor cells injection. "
        ],
        "rois":[
          {
            "x":3,
            "y":23,
            "x2":1788,
            "y2":1852
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D) Digitization of ERIC-PCR DNA fingerprints. Gel images were digitized by Image Lab 3.0 system (Bio-Rad). The peak area corresponded to the intensity of ERIC-PCR band shown in the gel image. "
        ],
        "rois":[
          
        ]
      }
    }
  },
  "1422321":{
    
  },
  "1423680":{
    
  },
  "142542":{
    
  },
  "1426351":{
    
  },
  "1426433":{
    
  },
  "1427075":{
    "Fig_1.tif":{
      "A":{
        "descriptions":[
          "(A) mRNA was prepared from the left ventricle "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1537,
            "y2":705
          }
        ]
      },
      "LV":{
        "descriptions":[
          "(LV) of WT mice 1 h after reperfusion, and real-time PCR analyses for cytokines were performed. Values normalized to GAPDH are expressed as fold change from the values of sham mice (n = 5 per group). "
        ],
        "rois":[
          
        ]
      },
      "B":{
        "descriptions":[
          "(B) Serum samples were collected from WT mice at 1 h after reperfusion, and we performed Bio-Plex analysis for cytokines (n = 5 per group). *P "
        ],
        "rois":[
          {
            "x":0,
            "y":706,
            "x2":1537,
            "y2":1934
          }
        ]
      }
    }
  },
  "143144":{
    
  },
  "1432456":{
    
  },
  "1432777":{
    
  },
  "1433087":{
    "Fig_1.tif":{
      "e":{
        "descriptions":[
          "(e), MNLM-HP-SWI "
        ],
        "rois":[
          
        ]
      },
      "f":{
        "descriptions":[
          "(f), and MIR-SWI "
        ],
        "rois":[
          {
            "x":6,
            "y":1266,
            "x2":2680,
            "y2":2537
          }
        ]
      },
      "a":{
        "descriptions":[
          "(a), SWI "
        ],
        "rois":[
          {
            "x":5,
            "y":5,
            "x2":3069,
            "y2":1259
          }
        ]
      },
      "b":{
        "descriptions":[
          "(b), NLM-SWI "
        ],
        "rois":[
          {
            "x":5,
            "y":5,
            "x2":3069,
            "y2":1259
          }
        ]
      },
      "g":{
        "descriptions":[
          "(g) images. The number of phase mask multiplications is set to 4. Enhanced visibility of venous structures without loss of tissue contrast is evident in ",
          "(g) compared to (b-f)."
        ],
        "rois":[
          {
            "x":6,
            "y":1266,
            "x2":2680,
            "y2":2537
          }
        ]
      },
      "c":{
        "descriptions":[
          "(c), IR-SWI "
        ],
        "rois":[
          {
            "x":5,
            "y":5,
            "x2":3069,
            "y2":1259
          }
        ]
      },
      "d":{
        "descriptions":[
          "(d), MNLM-SWI "
        ],
        "rois":[
          {
            "x":5,
            "y":5,
            "x2":3069,
            "y2":1259
          }
        ]
      }
    }
  },
  "1434160":{
    
  },
  "1435440":{
    
  },
  "1437963":{
    
  },
  "1440224":{
    
  },
  "1440235":{
    "Fig_7.tif":{
      "A":{
        "descriptions":[
          "(A) and T. citrina "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2204,
            "y2":1599
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) at the indicated rearing times. MMP-2 and MMP-9 were identified by their apparent molecular mass of 67 and 92 kDa, respectively, using pre-stained molecular weight markers (Bio Rad). Histograms in C and D represent results, expressed as mean ?? SD, after scanning densitometry and computerized analysis of gels from at least three independent experiments with different cell populations. Asterisks represent values statistically different from LPS-treated astrocytes (positive control) (One-way Anova followed by Tukey test; * = p"
        ],
        "rois":[
          
        ]
      }
    }
  }
}
